Oncogenic Activity and Sorafenib Sensitivity of ARAF p.S214C Mutation in Lung Cancer.

Saved in:
Bibliographic Details
Title: Oncogenic Activity and Sorafenib Sensitivity of ARAF p.S214C Mutation in Lung Cancer.
Authors: Lee C; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong., Mu W; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong., Chen XJ; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong., Chan MSM; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong., Chen Z; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong., Yeung SF; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong., Chan HHY; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong., Chow ST; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong., Ko BCB; Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong., Chan DW; School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China., Cho WC; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong., Lui VWY; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong.; Georgia Cancer Center, Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA., Tsui SKW; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong.
Source: Cancers [Cancers (Basel)] 2025 Jul 04; Vol. 17 (13). Date of Electronic Publication: 2025 Jul 04.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2072-6694
DOI:10.3390/cancers17132246